Keen Eye Overview
Keen Eye is a French health tech company that has developed a cutting-edge, AI-powered platform designed to accelerate and enhance the process of clinical trials, particularly in the field of pathology. Here is a detailed overview of their product:
What the Product Does
Keen Eye’s platform is focused on computational pathology, utilizing Deep Learning technology to support organizations conducting clinical trials. The platform is designed to improve the efficiency, reliability, and compliance of clinical trial assays, benefiting biologists, pathologists, and pharmaceutical companies.
Key Features and Functionality
AI-Powered Image Analysis
The platform employs advanced Deep Learning algorithms for digital image analysis, enabling the detection and quantification of biomarkers in clinical study protocols. This capability is crucial for standardized and efficient analysis in pathology.
GCLP Compliance
Keen Eye’s platform is fully compliant with Good Clinical Laboratory Practices (GCLP) principles, ensuring that all processes adhere to regulatory standards. This compliance is essential for maintaining the integrity of data and the safety of clinical trial subjects.
Quality Controls and Audit Trail
The platform implements robust quality controls throughout its workflows, including electronic signatures for records and a comprehensive audit trail that captures every action performed. This ensures transparency and accountability in all operations.
Customized Algorithm Design
Keen Eye leverages transfer learning techniques to accelerate the design of customized deep learning image analysis algorithms. This approach reduces the development time for high-quality models from several months to just a few weeks, through close collaboration between pathologists and computer scientists.
User-Friendly and Scalable
The platform is web-based and provides users with access to powerful computing resources from their own PCs. It is designed to be user-friendly, allowing pathologists to run digital image analysis efficiently and scale the deployment of algorithms as needed.
Performance and Regulatory Compliance
The platform offers a significant improvement in performance while contributing to regulatory compliance, thereby setting new standards in clinical image analysis. This enhances the reliability and efficiency of biomarker detection and quantification in clinical study protocols.
Conclusion
In summary, Keen Eye’s AI-powered platform is a transformative tool for clinical trials, offering advanced image analysis, strict regulatory compliance, robust quality controls, and customized algorithm design, all aimed at supporting the development of new therapies with better, faster, and more accurate analytics.